How to Buy Ultragenyx Pharmaceutical Stock
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally.
Ultragenyx Pharmaceutical stock last closed at $44.24, up 0.89% from the previous day, and has increased 4.51% in one year. It has overperformed other stocks in the Biotechnology industry by 0.27 percentage points. Ultragenyx Pharmaceutical stock is currently +40.36% from its 52-week low of $31.52, and -19.53% from its 52-week high of $54.98.
At the moment, there are 82.34M shares of RARE outstanding. The market cap of RARE is $3.64B. In the past 24 hours, 450,422 RARE shares were traded.
How to Buy Ultragenyx Pharmaceutical Stock
Not sure how to invest in Ultragenyx Pharmaceutical stock? Here's how.
- Figure out where to buy Ultragenyx Pharmaceutical stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Ultragenyx Pharmaceutical stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your method of payment and add your information.
- Evaluate Ultragenyx Pharmaceutical stock: The Ultragenyx Pharmaceutical ticker symbol is RARE. Is Ultragenyx Pharmaceutical stock a good investment? Should you buy shares of RARE? How do RARE's underlying business fundamentals look? Do top analysts think Ultragenyx Pharmaceutical is a good buy? Why has RARE's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if RARE is a good stock to buy).
- Execute your RARE buy order: Decide if you will purchase RARE shares at the current market price or use a limit order to purchase RARE stock at a given price.
- Monitor your RARE investment: Create a watchlist to watch your investment in Ultragenyx Pharmaceutical shares.
Step 1: Figure out where to buy Ultragenyx Pharmaceutical stock
You need a brokerage account to access the NASDAQ market and buy RARE shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to invest in RARE today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on a investment app, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring funds into your investment account.
Step 4: Evaluate Ultragenyx Pharmaceutical stock
Once you have selected the best place to buy Ultragenyx Pharmaceutical stock, it's critical to analyze their stock before you buy, so you actually understand the risk as well as the opportunity.
Overview of key RARE info
Fundamentals of RARE
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on RARE's stock page.
What is the fair value of RARE stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge RARE's fair value.
Using relative valuations measures:
- RARE may be overvalued based on its P/B ratio of 13.23x, relative to Biotechnology industry P/B ratio of 5.85x
You can access more valuation research on RARE's stock here.
RARE Financial Health Overview
Passed Financial Due Diligence Checks:
- RARE has cash burn of 519073000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the RARE balance sheet.
Failed Financial Due Diligence Checks:
- RARE has $577.21M in cash and short term investments. This is not sufficient to cover its annual cash burn of $519.07M.
- RARE profit margin has gone up by 0.55 percentage points in the past year, but the company is still unprofitable.
- RARE has a relatively high debt to equity ratio of 4.41.
- Total RARE debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the RARE balance sheet.
Is it a good time to buy RARE stock, according to analysts?
Out of 10 Wall Street analysts who research RARE, the consensus analyst rating on Ultragenyx Pharmaceutical is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Latest RARE Analyst Forecasts
Cory Kasimov, a top 23% analyst from JP Morgan maintains RARE with a strong buy rating and raises their RARE price target from $84.00 to $88.00, on Feb 27, 2024.
Whitney Ijem, a top 13% analyst from Canaccord Genuity maintains RARE with a strong buy rating and raises their RARE price target from $110.00 to $111.00, on Feb 21, 2024.
Joel Beatty, a top 24% analyst from Baird maintains RARE with a buy rating and raises their RARE price target from $57.00 to $68.00, on Jan 30, 2024.
Tiago Fauth, a bottom 4% analyst from Wells Fargo initiates coverage on RARE with a strong buy rating and announces their RARE price target of $72.00, on Dec 8, 2023.
Jeffrey Hung, a top 12% analyst from Morgan Stanley maintains RARE with a strong buy rating and lowers their RARE price target from $90.00 to $84.00, on Nov 3, 2023.
You can dig deeper into what analysts are forecasting on the Ultragenyx Pharmaceutical stock forecast page.
RARE Technicals
How is RARE performing as a company?
Last year, RARE revenue was $434.25M. In the last five year, RARE's revenue has increased by 53.18% per year. This was faster than the Biotechnology industry average of 28.56%.
You can analyze RARE's earnings and revenue performance here.
Are RARE insiders buying or selling the stock?
In the last year, executives and large shareholders at RARE have sold more shares than they have bought.
Eric Crombez, EVP and Chief Medical Officer of RARE, was the latest RARE insider to sell. They sold $6,262.20 worth of RARE stock on Apr 18, 2024.
Learn more about who owns RARE shares here.
Can I get consistent income from RARE stock?
No, Ultragenyx Pharmaceutical doesn't provide an income stream by paying out dividends.
What others are saying about RARE
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your RARE buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you need additional help with investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your RARE investment
Now that you own some RARE shares, you'll want to stay up-to-date on your investment.
Create a watchlist to get the latest updates about your RARE stock.
RARE Feed
How to Buy Stock in Ultragenyx Pharmaceutical
To reiterate, here are the 6 steps you need to take to buy Ultragenyx Pharmaceutical stock right now:
- Figure out where to buy Ultragenyx Pharmaceutical stock
- Sign up for your brokerage account
- Deposit money your investment account
- Evaluate Ultragenyx Pharmaceutical stock
- Execute your RARE buy order
- Monitor your RARE investment
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Ultragenyx Pharmaceutical, create your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.